Cercar
20/10/2025
GradCAM as an explicability method to evaluate the performance of deep learning models in classifying pediatric arteriovenous malformations (AVM) in arterial spin labeling sequences (ASL)
Romagosa, J, Mata, C, Benítez, R, Valls-Esteve, A, Bernaus, S, Ibnoulkhatib, M, Stephan-Otto, C, Munuera, J. GradCAM as an explicability method to evaluate the performance of deep learning models in classifying pediatric arteriovenous malformations (AVM) in arterial spin labeling sequences (ASL). Health Information Science and Systems. 2025; 13(1)DOI:10.1007/s13755-025-00377-z. PMID:41127713. IF:3.400(Q2/5D).
01/09/2025
ADEM and other common radiological patterns shared in children with MOG-IgG and antibody-negative autoimmune encephalitis
Olivé-Cirera, G, Falcioni, L, Fetta, A, Perez, EGF, Verdaguer, MG, Martinez, E, Sabaté, L, Saiz, A, Dalmau, J, Armangue, T. ADEM and other common radiological patterns shared in children with MOG-IgG and antibody-negative autoimmune encephalitis. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).
01/09/2025
Clinical features of children with MOG-IgG who fulfill criteria of multiple sclerosis and overlapping disorders
Perez, EGF, Olivé, G, Chen, LW, Paredes-Carmona, F, Nuñez-Enamorado, N, Duran, SB, Mendibe, MD, Visa-Reñe, N, Vasquez-Lopez, M, Felipe-Rucián, A, Romeu, G, Martinez, E, Blanco, Y, Sepulveda, M, Saiz, A, Dalmau, J, Armangue, T. Clinical features of children with MOG-IgG who fulfill criteria of multiple sclerosis and overlapping disorders. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).
01/09/2025
Tocilizumab Did Not Increase the Risk of Severe ICANS in 600 patients treated with CD19 CAR-T Therapy
Cabrera-Maqueda, JM, Perez, EGF, Smith, CS, Chamorro, FJH, García, MA, Velilla, G, Gil-Perotin, SG, Martin-Aguilar, L, Velasco, R, Castillo-Triviño, T, Garcia, JLC, García, PC, García, CI, Cacabelos, PP, González-Suárez, I, Cladera, MM, de Larraya, JGP, Molina, EG, Iglesias, GT, Gallego, MD, Alcántara, LA, Guerra-Fernández, V, Alba, MT, Planagumà, J, Martinez-Cibrian, N, Martínez, E, Blanco, Y. Tocilizumab Did Not Increase the Risk of Severe ICANS in 600 patients treated with CD19 CAR-T Therapy. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).